lamotrigine
Generic: lamotrigine
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
lamotrigine
Generic Name
lamotrigine
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
TABLET, CHEWABLE
Routes
Active Ingredients
lamotrigine 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68462-228
Product ID
68462-228_fc701d94-bfc5-44c4-8667-6414ee7226ed
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA079099
Listing Expiration
2027-12-31
Marketing Start
2009-02-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462228
Hyphenated Format
68462-228
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamotrigine (source: ndc)
Generic Name
lamotrigine (source: ndc)
Application Number
ANDA079099 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 100 TABLET, CHEWABLE in 1 BOTTLE (68462-228-01)
- 1000 TABLET, CHEWABLE in 1 BOTTLE (68462-228-10)
- 90 TABLET, CHEWABLE in 1 BOTTLE (68462-228-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fc701d94-bfc5-44c4-8667-6414ee7226ed", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0368462228012", "0368462229019"], "unii": ["U3H27498KS"], "rxcui": ["311264", "311265"], "spl_set_id": ["50fcf452-2d21-493e-a1dd-0c6ea9ac6184"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (68462-228-01)", "package_ndc": "68462-228-01", "marketing_start_date": "20090219"}, {"sample": false, "description": "1000 TABLET, CHEWABLE in 1 BOTTLE (68462-228-10)", "package_ndc": "68462-228-10", "marketing_start_date": "20090219"}, {"sample": false, "description": "90 TABLET, CHEWABLE in 1 BOTTLE (68462-228-90)", "package_ndc": "68462-228-90", "marketing_start_date": "20090219"}], "brand_name": "Lamotrigine", "product_id": "68462-228_fc701d94-bfc5-44c4-8667-6414ee7226ed", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "68462-228", "generic_name": "Lamotrigine", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "5 mg/1"}], "application_number": "ANDA079099", "marketing_category": "ANDA", "marketing_start_date": "20090219", "listing_expiration_date": "20271231"}